Incyte (INCY) Current Leases (2018 - 2026)
Incyte posted quarterly Current Leases of $4.4 million for Q1 2026, down 1.45% year-on-year from $4.5 million in Q1 2025, and down 2.28% on a QoQ basis from $4.5 million in Q4 2025.
Incyte (INCY) has 9 years of Current Leases data on file, last reported at $4.4 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases fell 1.45% year-over-year to $4.4 million; the trailing twelve-month figure through Mar 2026 stood at $4.4 million (down 1.45% YoY), and the FY2025 full-year result was $4.5 million, up 2.2% from the prior year.
- Current Leases for Q1 2026 stood at $4.4 million, down from $4.5 million in the prior quarter.
- Across five years, Current Leases topped out at $4.5 million in Q4 2025 and bottomed at $2.8 million in Q1 2022.
- The 5-year median for Current Leases is $3.7 million (2024), against an average of $3.7 million.
- The widest annual swing landed in 2022, when Current Leases slumped 76.02%; it then increased 28.5% in 2024.
- A 5-year view of Current Leases shows it stood at $3.2 million in 2022, then climbed by 8.18% to $3.4 million in 2023, then climbed by 28.5% to $4.4 million in 2024, then increased by 2.2% to $4.5 million in 2025, then fell by 2.28% to $4.4 million in 2026.
- The last three Current Leases figures came in at $4.4 million (Q1 2026), $4.5 million (Q4 2025), and $4.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 4.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.41 Mn |
| Dec 31, 2025 | 4.52 Mn |
| Sep 30, 2025 | 4.49 Mn |
| Jun 30, 2025 | 4.48 Mn |
| Mar 31, 2025 | 4.48 Mn |
| Dec 31, 2024 | 4.42 Mn |
| Sep 30, 2024 | 3.93 Mn |
| Jun 30, 2024 | 3.87 Mn |
| Mar 31, 2024 | 3.68 Mn |
| Dec 31, 2023 | 3.44 Mn |
| Sep 30, 2023 | 3.06 Mn |
| Jun 30, 2023 | 3.17 Mn |
| Mar 31, 2023 | 3.15 Mn |
| Dec 31, 2022 | 3.18 Mn |
| Sep 30, 2022 | 3.11 Mn |
| Jun 30, 2022 | 3.04 Mn |
| Mar 31, 2022 | 2.80 Mn |
| Dec 31, 2021 | 2.64 Mn |
| Sep 30, 2021 | 9.85 Mn |
| Jun 30, 2021 | 2.41 Mn |
| Mar 31, 2021 | 11.66 Mn |
| Dec 31, 2020 | 2.28 Mn |
| Sep 30, 2020 | 10.71 Mn |
| Jun 30, 2020 | 1.19 Mn |
| Mar 31, 2020 | 9.02 Mn |
| Dec 31, 2019 | 9.34 Mn |
| Jun 30, 2019 | 791,000.00 |
| Dec 31, 2018 | 18.70 Mn |